Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
Study to assess the antiviral efficacy, pharmacokinetics and tolerability of BILN 2061 ZW in a polyethyleneglycol 400 (PEG 400: ethanol) drinking solution given for two days bid in patients with chronic Hepatitis C Virus (HCV) infection.
Epistemonikos ID: 6f8ddde03b7be2a37f9ce35123a2315bc3da4c9d
First added on: Mar 23, 2020